Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain.
Saved in:
| Title: | Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. |
|---|---|
| Authors: | Rayson, Daniel1 daniel.rayson@nshealth.ca, Gandhi, Sonal2, Joy, Anil A.3, Brezden-Masley, Christine4, Gelmon, Karen A.5, Sehdev, Sandeep6, Cescon, David7, Chia, Stephen5 |
| Source: | Current Oncology. Dec2022, Vol. 29 Issue 12, p9891-9895. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11980052 |
|---|---|
| DOI: | 10.3390/curroncol29120778 |
